Gilead antiviral drug remdesivir flops in first trial
By Donato Paolo Mancini & Hannah Kuchler
New data on Gilead's remdesivir, released by accident, show no benefit for coronavirus patients. Company still sees ...
By Adam Feuerstein, Matthew Herper & Ed Silverman